Glytone Acne, acne treatment facial cleanser, 2% Salicylic Acid, 200 mL/6.7 FL Oz Bottle, Distributed by Genesis Pharmaceuticals, Inc. a subsidiary of Pierre Fabre, Parsippany, NJ 07054, UPC 3 04760-00413-2
Published May 7, 2014 · Recall initiated: April 1, 2014
Summary
FDA records drug Class III recall D-1285-2014, published May 7, 2014 and initiated April 1, 2014. Recalling firm: Genesis Pharmaceutical, Inc.; Status: Terminated; Reported quantity: 461 Bottles; Lot: Lot 54, Exp: 1/14/2016. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Stability Specifications: Out of specification results for viscosity in one lot of Glytone Acne Treatment Facial Cleanser.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Genesis Pharmaceutical, Inc.
- Distributor
- Nationwide
- Lot
- Lot 54, Exp: 1/14/2016
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAVenlafaxine Hydrochloride Extended-Release Tablets, 37.5 mg, packaged in a) 30-count bottles (NDCMay 7, 2014
- FDAMaximum Strength/Non-Drowsy Tussin DM Adult Maximum Strength, Cough Cold, Dextromethorphan HBr, USP, 10 mgMay 7, 2014
- FDAVenlafaxine Hydrochloride Extended-Release Tablets, 150 mg, packaged in a) 30-count bottles (NDC 41616-758-83,May 7, 2014
- FDALupron Depot (Leuprolide Acetate for Depot Suspension) Single Dose Administration Kit with prefilledMay 7, 2014
- FDA0.9% Sodium Chloride Irrigation, USP, 1000 mL,Not for Injection, Manufactured by Baxter HealthcareMay 7, 2014
- FDALupron Depot (Leuprolide Acetate for Depot Suspension) Single Dose Administration Kit with prefilledMay 7, 2014
Questions about this recall
Was Glytone Acne, acne treatment facial cleanser, 2% Salicylic Acid, 200 mL/6.7 FL Oz Bottle, Distributed by Genesis Pharmaceuticals, Inc. a subsidiary of Pierre Fabre, Parsippany, NJ 07054, UPC 3 04760-00413-2 recalled?
Yes. FDA published recall D-1285-2014 on May 7, 2014. Reported hazard: Failed Stability Specifications: Out of specification results for viscosity in one lot of Glytone Acne Treatment Facial Cleanser.
What should I do if I have this product?
Voluntary: Firm initiated · Letter